Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H 2 S‐Nrf2 signaling-Reference-Cited by-同舟云学术

Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H 2 S‐Nrf2 signaling

Published:2020-06-23 Issue:6 Volume:34 Page:697-707
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Chen Li¹^ORCID,Shi Rui²,She Xia³,Gu Chaochao¹,Chong Li¹,Zhang Lina¹,Li Rui¹

Affiliation:

1. Department of Neurology Shaanxi Provincial People’s Hospital 256 Friendship West Road, Beilin District Xi’an Shaanxi 710068 China

2. Department of Ophthalmology Shaanxi Provincial People's Hospital No. 256 Youyi West Road, Beilin District Xi'an City Shaanxi Province 710068 China

3. Nuclear Magnetic Resonance Room Shaanxi Provincial People’s Hospital 256 Friendship West Road, Beilin District Xi’an Shaanxi 710068 China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12576

Reference60 articles.

1. Alzheimer's disease

2. Potential therapeutic action of natural products from traditional Chinese medicine on Alzheimer's disease animal models targeting neurotrophic factors

3. Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials

4. Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

5. Efficacy and safety of mineralocorticoid receptor antagonists with ACEI/ARB treatment for diabetic nephropathy: a meta‐analysis;Zuo C.;Int. J. Clin. Pract.,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanism and therapeutic strategy of bile acids in Alzheimer’s disease from the emerging perspective of the microbiota–gut–brain axis;Biomedicine & Pharmacotherapy;2024-09

2. Effects of the mineralocorticoid receptor antagonist eplerenone in experimental autoimmune encephalomyelitis;The Journal of Steroid Biochemistry and Molecular Biology;2024-04

3. Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists;iScience;2024-02

4. Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar‐I disorder: A double‐blind, randomized, placebo‐controlled clinical trial;Brain and Behavior;2023-11-06

5. Neuroprotective Effect of Thiazolidine-2,4-dione Derivatives on Memory Deficits and Neuropathological Symptoms of Dementia on a Scopolamine-Induced Alzheimer’s Model in Adult Male Wistar Rats;ACS Chemical Neuroscience;2023-08-10